(19)

(11)

EP 4 333 979 A1

(12)

(43) Date of publication: 13.03.2024 Bulletin 2024/11 (21) Application number: 22799340.9 (22) Date of filing: 01.05.2022

(51) International Patent Classification (IPC):  A61P 25/00(2006.01) A61K 31/4045(2006.01) A61K 31/437(2006.01) A61K 31/407(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/4045; A61P 25/00; A61K 31/48; A61K 31/675; A61K 31/137 (86) International application number: PCT/US2022/027179 (87) International publication number: WO 2022/235529 (10.11.2022 Gazette 2022/45)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 03.05.2021 US 202163183579 P (71) Applicant: Mind Medicine, Inc. New York, NY 10007 (US)	(72) Inventors: BARROW, Robert Madison, Wisconsin 53703 (US) KARLIN, Daniel R. New York, New York 10013 (US) (74) Representative: Engstle, Verena  Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB Bankgasse 3 90402 Nürnberg 90402 Nürnberg (DE)